Doxorubicin induces cardiomyocyte dysfunction via a p38 MAP kinase-dependent oxidative stress mechanism
- 23 November 2004
- journal article
- Published by Elsevier in Cancer Detection Prevention
- Vol. 29 (3) , 294-299
- https://doi.org/10.1016/j.cdp.2004.07.008
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Hsp10 and Hsp60 modulate Bcl-2 family and mitochondria apoptosis signaling induced by doxorubicin in cardiac muscle cellsJournal of Molecular and Cellular Cardiology, 2003
- AT 1 Blockade Prevents Glucose-Induced Cardiac Dysfunction in Ventricular MyocytesHypertension, 2003
- Metallothionein Prevents Diabetes-Induced Deficits in Cardiomyocytes by Inhibiting Reactive Oxygen Species ProductionDiabetes, 2003
- Doxorubicin-induced apoptosis: Implications in cardiotoxicityMolecular and Cellular Biochemistry, 2002
- Abrogated Leptin-Induced Cardiac Contractile Response in Ventricular Myocytes Under Spontaneous HypertensionHypertension, 2002
- Characterization of Contractile Function in Diabetic Hypertensive Cardiomyopathy in Adult Rat Ventricular MyocytesJournal of Molecular and Cellular Cardiology, 2001
- Effects of doxorubicinol on excitation–contraction coupling in guinea pig ventricular myocytesEuropean Journal of Pharmacology, 2001
- Doxorubicin-induced late cardiotoxicity: delayed impairment of Ca2+-handling mechanisms in the sarcoplasmic reticulum in the ratCanadian Journal of Physiology and Pharmacology, 2000
- The protective role of manganese superoxide dismutase against adriamycin-induced acute cardiac toxicity in transgenic mice.Journal of Clinical Investigation, 1996
- Adriamycin cardiomyopathy in the rabbit: alterations in contractile proteins and myocyte functionCardiovascular Research, 1990